| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/19/2008 | CA2442135C Methods to culture circovirus |
| 08/14/2008 | WO2008098239A2 Paramyxovirus family inhibitors and methods of use thereof |
| 08/14/2008 | WO2008097115A1 Purified bacteriophage, its preparation and application |
| 08/14/2008 | WO2008096811A1 Attenuated minus-stranded rna virus |
| 08/14/2008 | WO2007135420A3 Defective interfering virus |
| 08/14/2008 | US20080194512 Compositions and methods for inhibiting viral replication |
| 08/14/2008 | US20080194002 Buffered polyhydroxy hydrocarbon solution comprising adenoviral vector; enhanced stability; gene therapy |
| 08/14/2008 | US20080194001 Chimeric Virus for the Treatment of Cancer |
| 08/14/2008 | US20080194000 Novel listeria monocytogenes bacteriophage and uses thereof |
| 08/14/2008 | US20080193483 Modified vaccinia Ankara (MVA); replication-deficient strain of vaccinia virus; poxvirus |
| 08/14/2008 | US20080193480 Infectious Bursal Disease Virus antigenic isolates and vaccines |
| 08/14/2008 | US20080193479 Method and Compositions for the Treatment of Hematologic Cancers |
| 08/14/2008 | US20080193418 Antibodies coupled to detectable marker; lysis; decontaminate surface or organism; detect, prevent and treat infection |
| 08/14/2008 | US20080193416 Vectors used to generate modified artificial chromosomes; cleavage sites that flank origin of replication, antibiotic resistance gene and sequence that encodes fluorescent protein |
| 08/14/2008 | US20080193413 Anti-Infective Agents |
| 08/14/2008 | US20080193373 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 08/14/2008 | CA2677659A1 Attenuated minus-stranded rna virus |
| 08/13/2008 | EP1956087A1 High production system for infectious hepatitis c virus particle |
| 08/13/2008 | EP1955719A1 Countermeasure against infection with floating virus |
| 08/13/2008 | EP1955703A1 Viruses for the treatment of cellular proliferative disorders |
| 08/13/2008 | EP1954811A2 Inducible expression systems |
| 08/13/2008 | EP0942928B2 Subunit respiratory syncytial virus vaccine preparation |
| 08/13/2008 | EP0835133B1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 08/13/2008 | EP0831899B1 Recombinant poxvirus-calicivirus compositions and uses |
| 08/13/2008 | EP0669987B1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 08/13/2008 | CN101243179A Method for production of antibody |
| 08/13/2008 | CN101240264A Porcine circovirus 2 type inactivated vaccine |
| 08/13/2008 | CN100410383C High-performance bioreactor for baculovirus of insects |
| 08/12/2008 | US7411058 Nucleic acid encoding protein of given sequence; temperature sensitivity, dominant interference, attenuation; vaccines |
| 08/12/2008 | US7410954 Adenovirus serotype 30 (Ad30) |
| 08/12/2008 | US7410801 Obtaining recombinant lambdoid bacteriophage with high density display of functional peptides and proteins on surface via viral propagation in microorganismal host |
| 08/12/2008 | US7410788 Compositions and methods for production of disulfide bond containing proteins in host cells |
| 08/12/2008 | US7410644 Recombinant pox virus for immunization against tumor-associated antigens |
| 08/12/2008 | CA2376236C Modification of biological elements |
| 08/07/2008 | WO2008092854A2 Papillomavirus e2 polypeptide used for vaccination |
| 08/07/2008 | US20080188640 Immunodeficiency recombinant poxvirus |
| 08/07/2008 | US20080188466 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction |
| 08/07/2008 | US20080187546 Method for Replicating Influenza Virus in Culture |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080184618 Adsorbing, binding deactivated viruses; therap for mammals infections; gastrointestinal disorders |
| 08/07/2008 | CA2675355A1 Papillomavirus vaccine |
| 08/07/2008 | CA2673579A1 Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages |
| 08/07/2008 | CA2659275A1 Chimeric influenza virus-like particles |
| 08/07/2008 | CA2657955A1 Chimeric virus-like particles |
| 08/06/2008 | EP1951865A1 Stabilizing formulations for recombinant viruses |
| 08/06/2008 | EP1725581B1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 08/06/2008 | EP1377671B1 Oncolytic adenoviral vectors |
| 08/06/2008 | EP1214410B1 Chimaeric plant viruses with mucin peptides |
| 08/06/2008 | EP1204739B1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 08/06/2008 | EP1108034B1 Attenuated salmonella spi2 mutants as antigen carriers |
| 08/06/2008 | CN101238209A 登革血清型2减毒株 Save dengue serotype 2 strain |
| 08/06/2008 | CN101235365A Highly effective method for producing adenovirus |
| 08/06/2008 | CN101235364A Newcastle disease virus D90 strain and application thereof |
| 08/06/2008 | CN101235363A Pig transmissible gastroenteritis virus vaccine strain and application thereof |
| 08/06/2008 | CN101234198A Method of preparing pig replication and respiration syndrome deactivation concentrated vaccine í«SD1 strainí» |
| 08/06/2008 | CN100408675C Avian embryo particulate biomass for the production of virus antigens |
| 08/05/2008 | US7407790 Recombinant double-stranded RNA phages and uses thereof |
| 08/05/2008 | US7407752 Using triplex formation as a tool in prevention of viral gene expression; viricides |
| 08/05/2008 | US7407744 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | US7407662 Modified virus comprising low cholesterol content for use as tool in preventing and treating viral infection; immunostimulants |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 07/31/2008 | WO2008091659A2 Methods and compositions for predicting and treating drug resistant strains of influenza virus |
| 07/31/2008 | WO2008089569A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | WO2008027084A3 Modified aav vectors having reduced capsid immunogenicity and use thereof |
| 07/31/2008 | US20080182807 gene therapy against tumors and cancer; expression vector includes insert into tumor an effective amount of polynucleotides encoding a functionally active p53, express p53 to first DNA damaging agent, contact tumor cell with first DNA damaging agent, and kill tumor cell |
| 07/31/2008 | US20080181914 an inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route |
| 07/31/2008 | CA2676481A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | CA2657626A1 Viral inhibitory nucleotide sequences and vaccines |
| 07/30/2008 | EP1950295A1 Phage display selection system for helper phages sensitive to proteolysis |
| 07/30/2008 | EP1949905A1 Reovirus for the treatment of cellular proliferative disorders |
| 07/30/2008 | EP1948800A1 Antiviral resistance mutants and applications thereof |
| 07/30/2008 | EP1948792A1 Conditionally replicating viruses and methods for cancer virotherapy |
| 07/30/2008 | EP1948229A2 Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 07/30/2008 | EP1423525B1 Recombinant mva capable of expressing structural hcv antigens |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP0776209B1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 07/30/2008 | CN101230336A Gm-negative ehv-mutants |
| 07/30/2008 | CN101230335A Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 07/30/2008 | CN101230334A Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 07/30/2008 | CN100406556C Virus inactivating agent, virus inactivating method, filter with the virus inactivating and air conditioner therewith |
| 07/29/2008 | US7405066 Genome of given DNA sequence; capable of lysing Propionibacterium for treatment of acne |
| 07/29/2008 | US7405039 Hepatitis B virus (HBV) variant with reduced sensitivity to entecavir (ETV) and/or lamivudine (LMV) for use as tool in screening viricidal agents and therapeutic protocols which prevent infection, replication and/or release of viral particles |
| 07/29/2008 | CA2332623C Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 07/24/2008 | WO2008086881A1 Genetically modified bacteriophages, in particular for combating pathogenic prokaryotes or their pathological effect, and its use and production |
| 07/24/2008 | WO2008033966A3 Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| 07/24/2008 | WO2008017956A3 Frozen stockpiling of influenza vaccines |
| 07/24/2008 | WO2007022425A9 Influenza recombinant subunit vaccine |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176218 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 07/24/2008 | US20080176209 Desolventizing, dehydration, dryness; for automated storing, tracking retrieving and analyzing of nucleic acid samples |
| 07/24/2008 | US20080175864 administering antiviral agents, very low density lipoproteins (VLDL) assembly inhibitors, such as small interfering RNA or antisense oligonucleotide directed against apolipoprotein B, or microsomal triglyceride transfer protein (MTP) inhibitors, to inhibit release of HCV from an HCV-infected cells |
| 07/24/2008 | US20080175863 immunogens and vaccines comprising myxovirus proteins having amino acid replacements; genetic engineering |
| 07/24/2008 | US20080175862 Recombinant Flavivirus Vaccines |
| 07/24/2008 | US20080175861 Modified polymerases and attenuated viruses and methods of use thereof |
| 07/24/2008 | US20080175859 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | US20080175836 Using human immunodeficiency viral nucleotide sequences as tool in developing vaccines against HIV infection |
| 07/24/2008 | US20080175818 Using replication-defective plasmid comprising p53 nucleotide sequences as as delivery tool for antitumor agents |
| 07/24/2008 | CA2675139A1 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus |